Grant Program for Advancing Continuous C-Peptide Monitoring Technologies
Breakthrough T1D is seeking applications for the Development of Continuous C-Peptide Monitoring Technologies Grant Program, aiming to revolutionize Type 1 diabetes research and care.
Program Details:
- Funding: Up to $900,000 over three years
- Eligibility: Academic institutions, non-profit research organizations, government research units, and for-profit companies (with matching funds)
- Focus: Developing sensor technologies for continuous C-peptide monitoring, detecting picomolar concentrations with high sensitivity, specificity, and stability
Key Research Areas:
- Biosensors: For C-peptide detection in biological fluids
- Sensor Validation: Through in vitro, ex vivo, or early clinical studies
- Preclinical Testing: In animal models
- Integration: With wearable, at-home, or user-friendly devices
Application Process:
- Prepare and submit a Letter of Intent (LOI) by December 4, 2025
- Await LOI notification (decisions released January 8, 2026)
- Submit full proposal by February 12, 2026 (only approved LOIs)
Why it Matters:
- C-peptide is a critical biomarker for beta-cell function and disease progression
- Current methods are infrequent and invasive
- Continuous monitoring can enable high-resolution data collection, better tracking of therapeutic impact, and personalized disease monitoring
Visit HERE for more grant opportunities.
